Диссертация (Электростимуляция как альтернативный способ физическим тренировкам у пациентов с хронической обструктивной болезнью легких), страница 21

García-Sidro, P. The CAT (COPD Assessment Test) questionnaire as apredictor of the evolution of severe COPD exacerbations / P. García-Sidro [et al.] //Respiratory Medicine. – 2015. – № 12 (109). – P. 1546–1552.113. Girault, C. Comparative physiologic effects of noninvasive assist-controland pressure support ventilation in acute hypercapnic respiratory failure / C. Girault [et122al.] // Chest. – 1997. – № 6 (111). – P. 1639–1648.114. Girou, E. Secular trends in nosocomial infections and mortality associatedwith noninvasive ventilation in patients with exacerbation of COPD and pulmonaryedema / E. Girou [et al.] // JAMA.

– 2003. – № 22 (290). – P. 2985–2991.115. Global strategy for the diagnosis, management, and prevention of chronicobstructive pulmonary disease (GOLD 2018). – 2018. – URL: https://goldcopd.org/wpcontent/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf.116. Gowda, A.A. Reliability of Vibrating Mesh Technology / A.A. Gowda, A.D.Cuccia, G.C. Smaldone // Respiratory Care.

– 2017. – № 1 (62). – P. 65 LP–69.117. Grinnan, D.C. Clinical review: respiratory mechanics in spontaneous andassisted ventilation / D.C. Grinnan, J.D. Truwit // Critical care (London, England). –2005. – № 5 (9). – P. 472–484.118. Groenewegen,K.H.Mortalityandmortality-relatedfactorsafterhospitalization for acute exacerbation of COPD / K.H. Groenewegen, A.M.W.J.

Schols,E.F.M Wouters // Chest. – 2003. – № 2 (124). – P. 459–467.119. Gudmundsson, G. Risk factors for rehospitalisation in COPD: role of healthstatus, anxiety and depression / G. Gudmundsson [et al.] // European RespiratoryJournal. – 2005. – № 3 (26). – P. 414–419.120. Guérin, C. Quantitative Analysis of Acid-Base Disorders in Patients WithChronic Respiratory Failure in Stable or Unstable Respiratory Condition / C. Guérin [etal.] // Respiratory Care. – 2010. – № 11 (55). – P.

1453–1463.121. Gulsvik, R. Acetazolamide improves oxygenation in patients withrespiratory failure and metabolic alkalosis / R. Gulsvik [et al.] // The clinical respiratoryjournal. – 2013. – № 4 (7). – P. 390–396.122. Haja Mydin, H. Anemia and performance status as prognostic markers inacute hypercapnic respiratory failure due to chronic obstructive pulmonary disease / H.Haja Mydin [et al.] // International journal of chronic obstructive pulmonary disease. –2013.

– № 8. – P. 151–157.123. Hansell, A.L. What do chronic obstructive pulmonary disease patients diefrom? Amultiple cause coding analysis / A.L. Hansell, J.A. Walk, J.B. Soriano //123European Respiratory Journal. – 2003. – № 5 (22). – P. 809–814.124. Heming, N. Population pharmacodynamic modeling and simulation of therespiratory effect of acetazolamide in decompensated COPD patients / N. Heming [etal.] // PloS one.

– 2014. – № 1 (9). – P. e86313.125. Hess, D.R. Aerosol Therapy During Noninvasive Ventilation or High-FlowNasal Cannula / D.R. Hess // Respiratory care. – 2015. – № 60 (6). – P. 880–893.126. Hilbert, G. Sequential use of noninvasive pressure support ventilation foracute exacerbations of COPD / G.

Hilbert [et al.] // Intensive Care Medicine. – 1997. –№ 9 (23). – P. 955–961.127. Ho, T.-W. In-Hospital and One-Year Mortality and Their Predictors inPatients Hospitalized for First-Ever Chronic Obstructive Pulmonary DiseaseExacerbations: A Nationwide Population-Based Study / T.-W. Ho [et al.] // PLoS ONE.– 2014. – № 12 (9). – P. e114866.128. Hoogendoorn, M. Case fatality of COPD exacerbations: a meta-analysis andstatistical modelling approach / M. Hoogendoorn [et al.] // The European respiratoryjournal. – 2011.

– № 3 (37). – P. 508–515.129. Hurst, J.R. Susceptibility to exacerbation in chronic obstructive pulmonarydisease / J.R. Hurst [et al.] // The New England journal of medicine. – 2010. – № 12(363). – P. 1128–1138.130. In chronic obstructive pulmonary disease, a combination of ipratropium andalbuterol is more effective than either agent alone. An 85-day multicenter trial.COMBIVENT Inhalation Aerosol Study Group // Chest.

– 1994. – № 5 (105). – C.1411–1419.131. Jensen, F.B. Red blood cell pH, the Bohr effect, and other oxygenationlinked phenomena in blood O2 and CO2 transport / F.B. Jensen / Acta physiologicaScandinavica. – 2004. – № 3 (182). – P. 215–227.132. Jones, P.W. Development and first validation of the COPD Assessment Test/ P.W. Jones [et al.] // European Respiratory Journal. – 2009. – № 3 (34). – P. 648–654.133. Jones, P.W.

Carbonic anhydrase inhibitors for hypercapnic ventilatoryfailure in chronic obstructive pulmonary disease / P.W. Jones, M. Greenstone // The124Cochrane database of systematic reviews. – 2001. – № 1. – P. CD002881.134. Jones, R.C. Derivation and validation of a composite index of severity inchronic obstructive pulmonary disease: the DOSE Index / R.C. Jones [et al.] //American journal of respiratory and critical care medicine. – 2009. – № 12 (180). – P.1189–1195.135. Kanner, R.E. Predictors of survival in subjects with chronic airflowlimitation / R.E.

Kanner [et al.] // American Journal of Medicine. – 1983. – № 2 (74). –P. 249–255.136. Keenan, S.P. Which patients with acute exacerbation of chronic obstructivepulmonary disease benefit from noninvasive positive-pressure ventilation? A systematicreview of the literature / S.P. Keenan [et al.] // Annals of internal medicine. – 2003. – №11 (138). – P. 861–870.137. Knaus, W.A. APACHE II: a severity of disease classification system / W.A.Knaus [et al.] // Critical care medicine.

– 1985. – № 10 (13). – P. 818–829.138. Kramer, N. Randomized, prospective trial of noninvasive positive pressureventilation in acute respiratory failure / N. Kramer [et al.] // American journal ofrespiratory and critical care medicine. – 1995. – № 6 (151). – P. 1799–1806.139. Krintel, J.J. Carbon dioxide elimination after acetazolamide in patients withchronic obstructive pulmonary disease and metabolic alkalosis / J.J. Krintel [et al.] //Acta anaesthesiologica Scandinavica. – 1983.

– № 3 (27). – P. 252–254.140. Lardner, A. The effects of extracellular pH on immune function / A Lardner// Journal of leukocyte biology. – 2001. – № 4 (69). – P. 522–530.141. Leidy, N.K. Evaluating symptoms in chronic obstructive pulmonary disease:validation of the Breathlessness, Cough and Sputum Scale / N.K. Leidy [et al.] //Respiratory medicine. – 2003. – № 97 Suppl A. – P. S59–70.142. Leidy, N.K. The breathlessness, cough, and sputum scale: the developmentof empirically based guidelines for interpretation / N.K. Leidy [et al.] // Chest.

– 2003. –№ 6 (124). – P. 2182–2191.143. Lindenauer, P.K. Outcomes Associated With Invasive and NoninvasiveVentilation Among Patients Hospitalized With Exacerbations of Chronic Obstructive125Pulmonary Disease / P.K. Lindenauer [et al.] // JAMA Internal Medicine. – 2014. – №12 (174). – P. 1982.144. López-Campos, J.L. European COPD Audit: design, organisation of workand methodology / J.L. López-Campos [et al.] // The European respiratory journal. –2013.

– № 2 (41). – P. 270–276.145. Lozano, R. Global and regional mortality from 235 causes of death for 20age groups in 1990 and 2010: a systematic analysis for the Global Burden of DiseaseStudy 2010 / R. Lozano [et al.] // The Lancet. – 2012. – № 9859 (380). – P. 2095–2128.146. Lun, C.-T. Differences in baseline factors and survival betweennormocapnia, compensated respiratory acidosis and decompensated respiratory acidosisin COPD exacerbation: A pilot study / C.-T. Lun [et al.] // Respirology. – 2016. – № 1(21).

– P. 128–136.147. Maccari, J.G. Inhalation therapy in mechanical ventilation / J.G. Maccari [etal.] // Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira dePneumologia e Tisilogia. – № 5 (41). – P. 467–472.148. Maheshwari, V. Utilization of noninvasive ventilation in acute carehospitals: a regional survey / V. Maheshwari [et al.] // Chest. – 2006. – № 5 (129). – P.1226–1233.149.

Mannino, D.M. Prevalence and outcomes of diabetes, hypertension andcardiovascular disease in COPD / D.M. Mannino [et al.] // European RespiratoryJournal. – 2008. – № 4 (32). – P. 962–969.150. Martinez, F.J. Predictors of mortality in patients with emphysema and severeairflow obstruction / F.J. Martinez [et al.] // American journal of respiratory and criticalcare medicine. – 2006. – № 12 (173). – P. 1326–1334.151. Matkovic, Z.

Predictors of adverse outcome in patients hospitalised forexacerbation of chronic obstructive pulmonary disease / Z. Matkovic [et al.] //Respiration; international review of thoracic diseases. – 2012. – № 1 (84). – P. 17–26.152. McGhan, R. Predictors of Rehospitalization and Death After a SevereExacerbation of COPD / R. McGhan [et al.] // Chest. – 2007. – № 6 (132). – P. 1748–1755.126153.